Abstract
As part of healthcare-associated infections prevalence survey, we examined the prevalence of antibiotic allergies among inpatients and the possibility to de-label reported penicillin and sulfa allergies. Results show that most of the patients with a penicillin or sulfa allergy label are eligible for either direct de-labeling or oral antibiotic challenge.